CRON

Cronos Group Inc
NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC

Key Statistics

Market Cap
$1.18B
P/E Ratio
16.89
EPS
$0.19
Beta
1.20
52W High
$3.61
52W Low
$2.28
50-Day MA
$3.26
200-Day MA
$2.82
Dividend Yield
—
Profit Margin
39.10%
Forward P/E
28.74
PEG Ratio
—

About Cronos Group Inc

Cronos Group Inc. is a cannabinoid company. The company is headquartered in Toronto, Canada.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$179.09M
Gross Profit (TTM)$77.04M
EBITDA$11.88M
Operating Margin15.40%
Return on Equity7.05%
Return on Assets-0.10%
Revenue/Share (TTM)$0.47
Book Value$2.88
Price-to-Book1.17
Price-to-Sales (TTM)6.60
EV/Revenue2.591
EV/EBITDA51.47
Quarterly Earnings Growth (YoY)126.80%
Quarterly Revenue Growth (YoY)58.40%
Shares Outstanding$368.41M
Float$186.99M
% Insiders49.14%
% Institutions15.49%

Historical Volatility

HV 10-Day
14.82%
HV 20-Day
23.48%
HV 30-Day
25.19%
HV 60-Day
38.63%
HV Rank
2.4%

Volatility is currently contracting

Analyst Ratings

Consensus ($2.48 target)
3
Buy
1
Hold

Latest News

Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season

TORONTO, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, announced today that for the third consecutive year it is bringing back its popular limited-edition Caramel Green Apple flavor to its best-selling lineup of SOURZ by Spinach® edibles. For the first time, this seasonal flavor will launch exclusively in the SOURZ by Spinach® Fully Blasted 10-pack, the #1 edible multipack in Canada1.

GlobeNewsWire10/13/2026Neutral
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026

TORONTO, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 third quarter earnings conference call on Thursday, November 5, 2026, at 8:30 a.m. ET. Cronos' senior management team will discuss the Company's financial results and will be available for questions from the investment community after prepared remarks.

GlobeNewsWire10/8/2026Neutral
Cronos Hosts 2026 Investor Day

TORONTO, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is hosting its first Investor Day today, September 24, 2026, at its Cronos Growing Company Inc. Kingsville location.

GlobeNewsWire9/24/2026Neutral
Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability

Cronos Group Inc. is upgraded to a Buy, driven by a best-in-class balance sheet and improved profitability. CRON boasts $827 million in cash, no debt, and strong international expansion, with adjusted gross margins reaching 46%. Profitability is supported by disciplined cost management and positive GAAP operating profit, distinguishing CRON from Canadian peers.

Seeking Alpha9/15/2026Positive
Cronos' brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabis company, is expanding its lineup of edible multipacks with the SOURZ by Spinach® Blue Raspberry Lemonade Fully Blasted multipack, featuring its first live resin gummy. This month the brand will also launch new flavors in its best-selling lineup of vape cartridges, Strawberry Banana and Sweet Citrus Punch.

GlobeNewsWire9/2/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CRON and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 10/17/2026